Cargando…
Long-term follow-up and successful treatment of pulmonary alveolar proteinosis without hypercholesterolemia with statin therapy: a case report
Pulmonary alveolar proteinosis (PAP) is a rare disorder characterized by the accumulation of excessive surfactant lipids and proteins in alveolar macrophages and alveoli. Oral statin therapy is a novel treatment for PAP with hypercholesterolemia. However, this treatment has never been described in a...
Autores principales: | Shi, Shenyun, Wang, Rujia, Chen, Ling, Li, Yan, Zhang, Yingwei, Xin, Xiaoyan, Yang, Shangwen, Wang, Yihua, Xiao, Yonglong, Xu, Kaifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113942/ https://www.ncbi.nlm.nih.gov/pubmed/33926277 http://dx.doi.org/10.1177/03000605211010046 |
Ejemplares similares
-
Assessment of Statin Treatment for Pulmonary Alveolar Proteinosis without Hypercholesterolemia: A 12-Month Prospective, Longitudinal, and Observational Study
por: Shi, Shenyun, et al.
Publicado: (2022) -
Quantitative chest CT assessment of pulmonary alveolar proteinosis with deep learning: a real-world longitudinal study
por: Shi, Shenyun, et al.
Publicado: (2022) -
Valuable Serum Markers in Pulmonary Alveolar Proteinosis
por: Shi, Shenyun, et al.
Publicado: (2019) -
Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis
por: McCarthy, Cormac, et al.
Publicado: (2018) -
Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies
por: Huang, Xinmei, et al.
Publicado: (2023)